Form 8-K - Current report:
SEC Accession No. 0001193125-18-220669
Filing Date
2018-07-18
Accepted
2018-07-18 17:01:10
Documents
19
Period of Report
2018-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d610765d8k.htm 8-K 24517
2 EX-1.1 d610765dex11.htm EX-1.1 171344
3 EX-10.1 d610765dex101.htm EX-10.1 297491
4 EX-10.2 d610765dex102.htm EX-10.2 105644
5 EX-10.3 d610765dex103.htm EX-10.3 107279
6 EX-99.1 d610765dex991.htm EX-99.1 354092
7 EX-99.2 d610765dex992.htm EX-99.2 274750
8 EX-99.3 d610765dex993.htm EX-99.3 9273
9 GRAPHIC g6107651.jpg GRAPHIC 19373
10 GRAPHIC g610765g00r78.jpg GRAPHIC 8216
11 GRAPHIC g610765g01n22.jpg GRAPHIC 4019
12 GRAPHIC g610765g14y84.jpg GRAPHIC 138620
13 GRAPHIC g610765g17l93.jpg GRAPHIC 71786
14 GRAPHIC g610765g21e98.jpg GRAPHIC 152202
15 GRAPHIC g610765g29d13.jpg GRAPHIC 16832
16 GRAPHIC g610765g43a12.jpg GRAPHIC 12236
17 GRAPHIC g610765g64g96.jpg GRAPHIC 230814
18 GRAPHIC g610765g65j68.jpg GRAPHIC 21543
19 GRAPHIC g610765g73u11.jpg GRAPHIC 165192
  Complete submission text file 0001193125-18-220669.txt   2505712
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 18958892
SIC: 2834 Pharmaceutical Preparations